GLP-1受容体作動薬、SGLT2阻害薬、心血管事象、重大腎事象、併用療法の影響について調べた研究「Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study」の結果が発表されました。
https://www.bmj.com/content/385/bmj-2023-078242
GLP-1受容体作動薬、SGLT2阻害薬、心血管事象、重大腎事象、併用療法の影響について調べた研究「Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study」の結果が発表されました。